Reading and Writing: How Far, How Fast & When?
Our CFO, David Peoples will be on a panel discussion with other leaders in synthetic biology at the SynBioBeta conference next week. The panel will examine the frontiers of genomic sequencing and synthesis highlighting the latest advances in instrumentation, informatics, and automation that are pushing beyond conventional limits. Hear how low-cost sequencing is becoming critical for enabling sectors like healthcare and agriculture to continue to scale.
Panel Discussion
SynBioBeta 2025
- Time: 11:25 AM - 11:55 AM PST
- Speaker: David Peoples Chief Financial and Business Officer at Ultima Genomics
- Location: Main Stage - Grand Ballroom 220A | GSBC25042
This session will examine the frontiers of genomic sequencing and synthesis, providing a critical assessment of the present capabilities and charting likely trajectories for future progress. Participants will highlight the latest advances in instrumentation, informatics, and automation that are pushing beyond conventional limits, while also considering emerging technologies poised to reshape the landscape of DNA reading and writing. By focusing on accuracy, throughput, and scalability, this discussion will illuminate the fundamental shifts now taking place and the new horizons they open for biological research and innovation.
Panelists:
Matt Hill – CEO - Elegen
Esteban Toro – Senior Director of Analytics - Twist Bioscience
Meenakshi Prabhune – Editor-In-Chief - The Scientist
Jason T. Gammack – CEO - Ansa Biotechnologies
David Peoples – Chief Financial & Business Officer - Ultima Genomics